TNFAIP3 is a CRC tumor suppressor but NLRP3 level is associated with poorer survival in patients with aggressive CRC and chronic intestinal inflammation, such as IBD, is considered a risk factor for the development of colorectal cancer (127). This evidence concerns the gene TNFAIP3 and colorectal carcinoma.